ScholarIQanswers from OpenAlex
Molecular Therapy — Methods & Clinical Development
JournalCitation impact & published research
Molecular Therapy — Methods & Clinical Development is a journal indexed in ScholarIQ from OpenAlex.
How many works does Molecular Therapy — Methods & Clinical Development have?
ScholarIQindexed works
Molecular Therapy — Methods & Clinical Development has 1,845 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Molecular Therapy — Methods & Clinical Development have?
ScholarIQcitation count
Molecular Therapy — Methods & Clinical Development has 49,811 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Molecular Therapy — Methods & Clinical Development?
ScholarIQh-index
Molecular Therapy — Methods & Clinical Development has an h-index of 92 in OpenAlex.
What is the article processing charge of Molecular Therapy — Methods & Clinical Development?
ScholarIQarticle processing charge
Molecular Therapy — Methods & Clinical Development lists an article processing charge of 3,900 USD in OpenAlex.
What is the OpenAlex record for Molecular Therapy — Methods & Clinical Development?
ScholarIQopenalex
The OpenAlex for Molecular Therapy — Methods & Clinical Development is on the source record.
What are the most-cited papers on Molecular Therapy — Methods & Clinical Development?
ScholarIQmost cited works
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
Liting You, Ruizhan Tong, Mengqian Li, Yuncong Liu, Jianxin Xue, You Lü
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells
Jonas Kath, Weijie Du, Alina Pruene, Tobias Braun, Bernice Thommandru, Rolf Turk, Morgan Sturgeon, Gavin Kurgan, Leila Amini, Maik Stein, Tatiana Zittel, Stefania Martini, Lennard Ostendorf, Andreas Wilhelm, Levent Akyüz, Armin Rehm, Uta E. Höpken, Axel Prüß, Annette Künkele, Ashley M. Jacobi, Hans‐Dieter Volk, Michael Schmueck‐Henneresse, Renata Stripecke, Petra Reinke, Dimitrios L. Wagner
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal
Ilana Moscatelli, Elena Almarza, Axel Schambach, David Ricks, Ansgar Schulz, Christopher D. Herzog, Kim Henriksen, Maria Askmyr, Jonathan D. Schwartz, Johan Richter
Transgene-host cell interactions mediate significant influences on the production, stability, and function of recombinant canine FVIII
Bredon Crawford, Margareth C. Ozelo, Kenichi Ogiwara, James Ahlin, Silvia Albánez, Carol Hegadorn, Lori Harpell, Christine Hough, David Lillicrap